Entries of Uharek, Lutz on the publication server

Alchalby, Haefaa, Zabelina, Tatjana, Wolff, Daniel, Kobbe, Guido, Bornhäuser, Martin, Baurmann, Herrad, Nagler, Arnon, Bethge, Wolfgang A., Stelljes, Matthias, Uharek, Lutz, Schaefer-Eckert, Kerstin, Burchert, Andreas, Corradini, Paolo, Schubert, Joerg E. A., Kaufmann, Martin, Dreger, Peter, Wulf, Gerald, Stuhler, Gernot, Kvasnicka, Hans-Michael , Zander, Axel R., Niederwieser, Dietger, Brand, Ronald, de Witte, Theo M. and Kröger, Nicolaus (2011) Long Term Follow-up of the Prospective Multicenter Study of reduced-Intensity Allogeneic Stem Cell Transplantation for Primary or Post ET/PV Myelofibrosis. Blood 118 (21), p. 1019. Fulltext not available.

Kröger, Nicolaus, Holler, Ernst, Kobbe, Guido, Bornhäuser, Martin, Schwerdtfeger, Rainer, Baurmann, Herrad, Nagler, Arnon, Bethge, Wolfgang, Stelljes, Matthias, Uharek, Lutz, Wandt, Hannes, Burchert, Andreas, Corradini, Paolo , Schubert, Jörg, Kaufmann, Martin, Dreger, Peter, Wulf, Gerald G., Einsele, Hermann, Zabelina, Tatjana, Kvasnicka, Hans Michael , Thiele, Jürgen, Brand, Ronald, Zander, Axel R., Niederwieser, Dietger and de Witte, Theo M. (2009) Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Blood 114 (26), pp. 5264-5270. Fulltext not available.

Kroeger, Nicolaus, Holler, Ernst, Kobbe, Guido, Bornhaeuser, Martin, Schwerdtfeger, Rainer, Nagler, Arnon, Bethge, Wolfgang, Stelljes, Matthias, Uharek, Lutz, Wandt, Hannes, van Os, Marleen, Burchert, Andreas, Corradini, Paolo, Schubert, Joerg, Kaufmann, Martin, Dreger, Peter, Wulf, Gerald, Einsele, Hermann, Gramatzki, Martin, Zabelina, Tatjana, Bacher, Ulrike, Zander, Axel, Heinzelmann, Marion, Kvasnicka, Michael, Thiele, Juergen, Niederwieser, Dietger and de Witte, Theo (2007) Dose-Reduced Conditioning Followed by Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis. Results from a Multicenter Prospective Trial of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Blood 110 (11), p. 683. Fulltext not available.